A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions

Refractory Diabetic Macular Edema

Interventions

DRUG

Episcleral Dexamethasone

Sequestered Transscleral, Controlled-Release Dexamethasone

Trial Locations (1)

Stanford Medicine Ophthalmology, Palo Alto

All Listed Sponsors

lead

Targeted Therapy Technologies, LLC

INDUSTRY